Bernard Stang manages a portfolio of investments in the private and listed sectors and has enjoyed over 40 years of operational leadership in healthcare businesses.
He is a co-founder and director of the Regional Health Care Group of companies, and has been the chief executive of Stangcorp, Stoneville Brunswick Property.
Mr Stang is a director of Novapharm Research and a director of Weizmann Australia which represents the Weizmann Institute of Science in Australia, and the Institute has established the Garvan-Weizmann Centre of Cellular Genomics in Sydney, in joint venture with the Garvan Institute.